Zobrazeno 1 - 10 of 27 pro vyhledávání: '"E. Tsiompanou"'
1
Hippocrates: timeless still
Autor: Spyros G Marketos, E Tsiompanou
Publikováno v: Journal of the Royal Society of Medicine. 106:288-292
. . I wish I had known of these views of Hippocrates before I had published, for they seem almost identical with mine merely a change of terms and an application of them to classes of facts necessarily unknown to the old philosopher. The whole case i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f58c774bcec0b3cfffdb7c0eda776e
https://doi.org/10.1177/0141076813492945
Zobrazit plný text záznamu
2
Higher Dose and Dose-Rate in Smaller Tumors Result in Improved Tumor Control
Autor: E Tsiompanou, A Mayer, AA Flynn, Richard H. J. Begent, R Boden, RB Pedley, Jason L. J. Dearling
Publikováno v: Cancer Investigation. 21:382-388
Small tumors are more sensitive to radioimmunotherapy (RIT) than larger ones. A greater proportion of viable radiosensitive areas in small tumors, higher antibody uptake, and radiation dose may be responsible. Six groups of mice with small (median tu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::05b446ad4080f08344304ee2eb68fa7b
https://doi.org/10.1081/cnv-120018229
Zobrazit plný text záznamu
6
Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer
Autor: G.M. Boxer, E. Tsiompanou, T. Levine, R. Watson, R.H.J. Begent
Publikováno v: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 26(1)
This manuscript reports a carefully controlled study of patients with Dukes B colorectal cancer (Dukes stage A, n=12 and Dukes stage B, n=44). Immunohistochemistry has been used to demonstrate reactivity for vascular endothelial growth factor (VEGF),
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50fd574a21152bf119c45e5c06167e61
https://pubmed.ncbi.nlm.nih.gov/15741766
Zobrazit plný text záznamu
7
Higher dose and dose-rate in smaller tumors result in improved tumor control
Autor: A, Mayer, E, Tsiompanou, A A, Flynn, R B, Pedley, J, Dearling, R, Boden, R H J, Begent
Publikováno v: Cancer investigation. 21(3)
Small tumors are more sensitive to radioimmunotherapy (RIT) than larger ones. A greater proportion of viable radiosensitive areas in small tumors, higher antibody uptake, and radiation dose may be responsible. Six groups of mice with small (median tu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::706223dfb82943b8d473d511e81d2ff5
https://pubmed.ncbi.nlm.nih.gov/12901284
Zobrazit plný text záznamu
8
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours
Autor: L D Hope-Stone, D O'Malley, Hassan Shahbakhti, Surinder K. Sharma, E Tsiompanou, Ajw Hilson, Richard H. J. Begent, L Gumbrell, David C. Blakey, Daniel Hochhauser, K L Adamson, Janet Martin, A J Green, SD Webley, A Robbins, L Sena, R. J. Francis, Caroline J. Springer
Publikováno v: British Journal of Cancer
Antibody-directed enzyme prodrug therapy is a targeted therapy in which a prodrug is activated selectively at the tumour site by an enzyme, which has been targeted to the tumour by an antibody (antibody-enzyme conjugate). Previous clinical trials hav
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2f37d304ba68b96192d5ba70661f029
https://pubmed.ncbi.nlm.nih.gov/12237768
Zobrazit plný text záznamu
9
Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody
Autor: A, Mayer, E, Tsiompanou, D, O'Malley, G M, Boxer, J, Bhatia, A A, Flynn, K A, Chester, B R, Davidson, A A, Lewis, M C, Winslet, A P, Dhillon, A J, Hilson, R H, Begent
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 6(5)
In radioimmunoguided surgery (RIGS), a radiolabeled antibody is given i.v. before surgery and a hand-held gamma-detecting probe is used to locate tumor in the operative field. The rapid blood clearance and good tumor penetration of single-chain Fv an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4db5c92dd10bd5a3aae4ed1ae6edb3df
https://pubmed.ncbi.nlm.nih.gov/10815889
Zobrazit plný text záznamu
10
Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer
Autor: K, Albanopoulos, A, Armakolas, M M, Konstadoulakis, E, Leandros, E, Tsiompanou, E, Tsiobanou, S, Katsaragakis, D, Alexiou, G, Androulakis
Publikováno v: The American journal of gastroenterology. 95(4)
The discovery of antibodies against carcinoembryonic antigen (CEA) in patients with digestive cancers, in the late 1970s, initiated a number of studies on the role of these antibodies in patients with cancers of the GI tract. Our aim was to determine
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd5a594776cfa7b52387691bc68e659
https://pubmed.ncbi.nlm.nih.gov/10763959
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje